Discontinued drugs in 2008: cardiovascular drugs.
This perspective is part of an annual series of papers discussing drugs dropped from clinical development in the previous year. Specifically, this paper focuses on the 16 cardiovascular drugs discontinued in 2008. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I-III clinical trials.
Zhang
Xu-Song
XS
China Pharmaceutical University, Center for Instrumental Analysis, Ministry of Education, Key Laboratory of Drug Quality Control & Pharmacovigilance, 210009 Nanjing, PR China. yxzxs@msn.com
Xiang
Bing-Ren
BR
D000818:Animals; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000639:trends; D000075202:Contraindications; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends; D006801:Humans; D010601:Pharmacology, Clinical / Q000639:trends; D013997:Time Factors
D002317:Cardiovascular Agents